Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to Companies who have applied for FDA Drug Approval
FDA Drug Approval Applications Sponsored by NOVO NORDISK INC
Application Number
Drugs/Products
Application Type
Most Recent Label Available Flag
Current Patent Flag
Action Type
Chemical Type
Ther Potential
Orphan Code
017926
INSULIN
REGULAR INSULIN
New Drug Application
Approval
New manufacturer
(S) Standard review drug
017929
NPH INSULIN
New Drug Application
Approval
New manufacturer
(S) Standard review drug
017996
SEMILENTE INSULIN
New Drug Application
Approval
New manufacturer
(S) Standard review drug
017997
ULTRALENTE INSULIN
New Drug Application
Approval
New manufacturer
(S) Standard review drug
017998
LENTE INSULIN
New Drug Application
Approval
New manufacturer
(S) Standard review drug
018193
VELOSULIN
New Drug Application
Approval
New manufacturer
(S) Standard review drug
018194
INSULIN INSULATARD NPH NORDISK
New Drug Application
Approval
New manufacturer
(S) Standard review drug
018195
INSULIN NORDISK MIXTARD (PORK)
New Drug Application
Approval
New manufacturer
(S) Standard review drug
018381
REGULAR PURIFIED PORK INSULIN
New Drug Application
Approval
New manufacturer
(S) Standard review drug
018382
SEMILENTE
New Drug Application
Approval
New formulation
(S) Standard review drug
018383
LENTE
New Drug Application
Approval
New manufacturer
(S) Standard review drug
018384
LENTARD
New Drug Application
Approval
New combination
(S) Standard review drug
018385
ULTRALENTE
New Drug Application
Approval
New formulation
(S) Standard review drug
018623
NPH PURIFIED PORK ISOPHANE INSULIN
New Drug Application
Approval
New manufacturer
(S) Standard review drug
018777
NOVOLIN L
New Drug Application
Approval
New formulation
(S) Standard review drug
018778
NOVOLIN R
New Drug Application
Approval
New formulation
(S) Standard review drug
019065
NOVOLIN N
New Drug Application
Approval
New formulation
(S) Standard review drug
019441
NOVOLIN 70/30
New Drug Application
Approval
New combination
(S) Standard review drug
019449
INSULATARD NPH HUMAN
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019450
VELOSULIN BR HUMAN
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019721
NORDITROPIN
New Drug Application
Approval
New manufacturer
(S) Standard review drug
(V) Orphan drug
019938
NOVOLIN R
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019959
NOVOLIN N
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019965
NOVOLIN L
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019991
NOVOLIN 70/30
New Drug Application
Approval
New manufacturer
(S) Standard review drug
020741
PRANDIN
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
020908
VAGIFEM
New Drug Application
Approval
New formulation
(S) Standard review drug
020986
NOVOLOG
NOVOLOG FLEXPEN
NOVOLOG FLEXTOUCH
NOVOLOG INNOLET
NOVOLOG PENFILL
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
021028
VELOSULIN BR
New Drug Application
Approval
New formulation
(S) Standard review drug
021148
NORDITROPIN
NORDITROPIN FLEXPRO
NORDITROPIN NORDIFLEX
New Drug Application
Approval
New formulation
(S) Standard review drug
021172
NOVOLOG MIX 70/30
NOVOLOG MIX 70/30 FLEXPEN
NOVOLOG MIX 70/30 PENFILL
New Drug Application
Approval
New combination
(S) Standard review drug
021536
LEVEMIR
LEVEMIR FLEXPEN
LEVEMIR FLEXTOUCH
LEVEMIR INNOLET
LEVEMIR PENFILL
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
021810
NOVOLOG MIX 50/50
New Drug Application
Approval
New formulation
(S) Standard review drug
022001
ACTIVELLA
New Drug Application
Approval
New indication
(S) Standard review drug
022341
VICTOZA
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
022386
PRANDIMET
New Drug Application
Approval
New combination
(S) Standard review drug
040312
INNOFEM
Abbreviated New Drug Application
Approval
203313
RYZODEG 70/30
New Drug Application
Approval
New combination
(S) Standard review drug
203314
TRESIBA
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
206321
SAXENDA
New Drug Application
Approval
10
(S) Standard review drug
Back to Companies who have applied for FDA Drug Approval